Course Overview
This course aims to provide knowledge and skills for patients on the topic of biosimilars, a class of biologic drugs or medical therapies that are highly similar to an existing originator medication that is off patent.
Biosimilars represent a rapidly growing area in pharmaceutical development, treatment options, and patient care that require an evidence-informed implementation approach.
As awareness and use of biosimilars increases globally, this course will provide information and guidance to support patient understanding of the effective and safe use of biosimilars in clinical settings.
The course will focus on enhancing knowledge and skills for patients and caregivers related to biosimilars.
The course will utilize a modular approach to provide content that is accessible and informative to all learners, and provide an introduction to biosimilar medications including what they are, regulatory processes, access, and discussing biosimilars with your healthcare provider.
This is an online self-directed course. There are no instructor-led activities.
More News
Image
Faces of PharmSci: Alexa Muir
Supervised by Associate Professor Lisa McCarthy, Alexa Muir is a second-year MSc student whose research explores how optimizing medication use can improve health and quality of life for older adults in long-term care.
Read More
Image
Designing health professions curriculum for a changing world
In response to rapid health system change, the Leslie Dan Faculty of Pharmacy launched Canada’s first three-year integrated PharmD program with early, scalable student engagement in curriculum design—an approach now published in Medical Teacher.
Read More
Image
Five students recognized for leadership with University of Toronto award
Five students have contributed to creating a strong academic and social environment at the Leslie Dan Faculty of Pharmacy through their leadership in student groups.
Read More